Curetis

Curetis is a molecular diagnostics company that has developed a medical sample-to-answer platform called Unyvero. The company offers automated syndromic testing for severe infections, with the Unyvero system providing rapid results in under 5 hours.

Curetis is a molecular diagnostics company which has developed a medical sample-to-answer platform called Unyvero. The company's mission is to provide clinicians with actionable molecular insights when every minute counts, and it has achieved critical regulatory milestones and expanded its global distributor footprint. It successfully brought the Unyvero system to the European market, establishing its landmark Pneumonia panel in premium hospital networks. The company continues to scale its syndromic testing menu and advance multiplex PCR technology.

• Unyvero A50 Solution

  Rapid molecular diagnostic solution with broad coverage of pathogens and resistance markers, providing results in less than 5 hours.

• Unyvero Platform

  Consists of the Unyvero System and Application-specific Unyvero Cartridges, utilizing multiplex PCR technology to detect microorganisms and antibiotic resistance markers.

• Unyvero Application Cartridges

  Contains all components required for DNA isolation, amplification, and detection, offering broad panels for syndromic testing.

• 2021.11.04

  Reported2021.11.04

  OpGen announces Albert Weber’s appointment as CFO[5]OpGen宣布任命Albert Weber为首席财务官biospace.com

  OpGen announced that Albert Weber would become its Chief Financial Officer and Managing Director of subsidiary Curetis GmbH, effective January 1, 2022. The appointment was announced on November 4, 2021.

Read more

1. 1Curetis | Automated Syndromic Testing & Molecular Diagnosticscuretis.com
2. 2About us | Curetis Gmbhcuretis.com
3. 3Unyvero Platform & Syndromic Panels | Curetiscuretis.com
4. 4Curetiswikidata.org
5. 5OpGen宣布任命Albert Weber为首席财务官biospace.com